57600
IL-2 human
≥98% (GE), recombinant, expressed in E. coli, liquid
別名:
IL-2, TCGF, hIL-2
ログインで組織・契約価格をご覧ください。
サイズを選択してください
この商品について
Biological source:
human
Recombinant:
expressed in E. coli
Form:
liquid
Mol wt:
Mr ~15500
製品名
インターロイキン-2 ヒト, recombinant, expressed in E. coli, ~10000 U/mL
biological source
human
recombinant
expressed in E. coli
form
liquid
mol wt
Mr ~15500
packaging
vial of 1 mL
concentration
~10000 U/mL
color
colorless
UniProt accession no.
shipped in
dry ice
storage temp.
−70°C
Quality Level
Gene Information
human ... IL2(3558)
Biochem/physiol Actions
IL-2依存性リンパ球の増殖を促します。IL-2のアミノ酸配列が報告されています。
Disclaimer
-20°Cで安定です。凝集が生じて見かけ上の活性が失われることがあるため、適当量を調製し凍結・解凍の繰返しを避けてください。
Other Notes
1Uは、CTLL-2細胞を用いるMTTアッセイ(比色法)の活性単位に相当します。
販売制限が適用される場合がございます。
Packaging
1バイアルに10,000ユニットが含まれています。
Physical form
Dulbecco-PBS溶液 (1mg/mL BSA含有, 無色透明)。
保管分類
10 - Combustible liquids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Interleukin 2.
K A Smith
Annual review of immunology, 2, 319-333 (1984-01-01)
S Gillis et al.
Journal of immunology (Baltimore, Md. : 1950), 120(6), 2027-2032 (1978-06-01)
Several soluble factors have recently been associated with the proliferation and differentiation of thymus-derived lymphocytes. One of these factors present in medium conditioned by T cell mitogen-stimulated lymphocytes has the ability to promote the long-term culture of normal and antigen-specific
R J Robb et al.
Proceedings of the National Academy of Sciences of the United States of America, 81(20), 6486-6490 (1984-10-01)
Human interleukin 2 was separated into multiple molecular forms by selective immunoaffinity chromatography and chromatofocusing. For the most part, this heterogeneity was attributed to variations in glycosylation of the threonine residue in position 3 of the polypeptide chain. The various
Cecilie Brekke Rygh et al.
PloS one, 9(9), e108414-e108414 (2014-10-01)
There are currently no established radiological parameters that predict response to immunotherapy. We hypothesised that multiparametric, longitudinal magnetic resonance imaging (MRI) of physiological parameters and pharmacokinetic models might detect early biological responses to immunotherapy for glioblastoma targeting NG2/CSPG4 with mAb9.2.27
Nabil Ahmed et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33(15), 1688-1696 (2015-03-25)
The outcome for patients with metastatic or recurrent sarcoma remains poor. Adoptive therapy with tumor-directed T cells is an attractive therapeutic option but has never been evaluated in sarcoma. We conducted a phase I/II clinical study in which patients with
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）